SomaLogic (FRA:76X0) Debt-to-Revenue : 0.03 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SomaLogic Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

SomaLogic's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €0.00 Mil. SomaLogic's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €2.59 Mil. SomaLogic's annualized Revenue for the quarter that ended in Sep. 2023 was €82.64 Mil. SomaLogic's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 0.03.

SomaLogic Debt-to-Revenue Historical Data

The historical data trend for SomaLogic's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomaLogic Debt-to-Revenue Chart

SomaLogic Annual Data

Trend

Dec20

Dec21

Dec22

Debt-to-Revenue

0.66

0.03

SomaLogic Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Revenue	Get a 7-Day Free Trial								-	0.03	-	-	0.03

Competitive Comparison of SomaLogic's Debt-to-Revenue

For the Health Information Services subindustry, SomaLogic's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SomaLogic's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SomaLogic's Debt-to-Revenue falls into.

SomaLogic Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SomaLogic's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.338	+	0)	/	92.197
	=	0.03

SomaLogic's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	2.589)	/	82.636
	=	0.03

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.

SomaLogic Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of SomaLogic's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

SomaLogic (FRA:76X0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SomaLogic Inc (FRA:76X0) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2945 Wilderness Place, Boulder, CO, USA, 80301

Website

https://www.somalogic.com

SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

SomaLogic (FRA:76X0) Headlines

No Headlines